Finnrick - Ensuring a Safer and More Transparent Supply Chain
Shandong Aishi Biotechnology

Shandong Aishi Biotechnology
Retatrutide

Finnrick tested 7 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Shandong Aishi Biotechnology between 24 Oct 2025 and 29 Dec 2025. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).

Finnrick Rating™
E
BAD
Shandong Aishi Biotechnology
Retatrutide
Tested 7 Samples
Last test 29 Dec 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from Shandong Aishi Biotechnology

Samples are tested in commercial labs

Tests Count

7

Scores

AVG6.4MIN0.8MAX10.0

Last

29 Dec 2025

First

24 Oct 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
29 Dec 2025View0.810mg0.5mg-95.0%73.18%(no batch ID)No Label / Silver Crimp / Yellow CapLab EPublic
18 Dec 2025View5.530mg34.1mg+13.7%99.80%(no batch ID)Green Label / Silver Crimp / Blue Cap Lab GPublic
16 Dec 2025View5.920mg17.9mg-10.5%99.70%(no batch ID)No Label / Silver Crimp / Pink Cap Lab GPublic
25 Nov 2025View10.010mg10.4mg+4.0%99.95%Sep 15, 2025No Label / Silver Crimp / Yellow CapLab EPublic
4 Nov 2025View5.110mg11.3mg+13.0%99.60%(no batch ID)No Label / Silver Crimp / White CapLab GPublic
29 Oct 2025View8.05mg4.78mg-4.4%99.95%(no batch ID)No Label / Silver Crimp / Blue CapLab EPublic
24 Oct 2025View9.220mg21.2mg+6.0%99.70%Sept 19, 2025No Label / Silver Crimp / Blue CapLab GPublic